<sup>125</sup>I粒子永久性组织间植入治疗浅表恶性转移肿瘤

张宏伟; 李庆新; 刘惠萍; 晁栋; 孟辉; 张宏伟; 李庆新; 刘惠萍; 晁栋; 孟辉

doi:10.3760/cma.j.issn.1673-4114.2012.03.004

[1]

Ragde H, Elgamal AA, Snow PB, et al. Ten-year disease free survival after thransperineal sonography-guided iodine-125 brachytherapy with or without 45-gray external beam irraddiation in the treatment of patients with clinicalized, low to high gleason grade prostate carcinoma. Cancer, 1998, 83(5): 989-1001.

[2]

Videtic GM, Gaspar LE, Zamorano L, et al. Use of the RTOG recursive partitioning analysis to validate the benefit of iodine-125 implants in the primary treatment of malignant gliomas. Int J Radiat Oncol Biol Phys, 1999, 45(3): 687-692.

[3]

孙燕.癌症疼痛处理的基本原则.中国肿瘤, 1999, 8(2): 55-56.

[4]

赵恩民, 肖水芳, 秦永, 等. ¹²⁵I放射性密封源永久性置入治疗5例晚期头颈部癌疗效观察.临床耳鼻咽喉科杂志, 2004, 18(6): 348-352.

[5]

法逸华, 苏成海, 黄钢. ¹²⁵I粒子近距离照射在肿瘤治疗中的应用.国外医学放射医学核医学分册, 2003, 27(3): 115.

[6]

王洪武.现代肿瘤靶向治疗技术.北京:中国医药科技出版社, 2004: 324-353.

[7]

申文江, 王绿化, 夏延毅.放射治疗学新技术进展.北京:北京科学技术出版社, 2003: 199-200.